Skip to content


Azilect, Rasagiline ratiopharm (rasagiline) is a small molecule pharmaceutical. Rasagiline was first approved as Azilect on 2005-02-21. It is used to treat parkinson disease in the USA. It has been approved in Europe to treat parkinson disease. The pharmaceutical is active against amine oxidase [flavin-containing] B. In addition, it is known to target hypothetical protein. Azilect's patents are valid until 2027-08-27 (FDA).
Trade Name Azilect, Rasagiline ratiopharm
Common Name Rasagiline
Indication parkinson disease
Drug Class Mao inhibitors, type B
Get full access now